# Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

> **NCT00108862** · PHASE4 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 809 (actual)

## Conditions studied

- HIV Infection
- Tuberculosis

## Interventions

- **OTHER:** Strategy: Immediate ART
- **OTHER:** Strategy: Deferred ART

## Key facts

- **NCT ID:** NCT00108862
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 809 (ACTUAL)
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108862, "Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00108862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*